Article
Histone modifications and Sp1 promote GPR160 expression in bone cancer pain within rodent models
24 Oct 2024
Abstract excerpt
Bone cancer pain (BCP) affects ~70% of patients in advanced stages, primarily due to bone metastasis, presenting a substantial therapeutic challenge. Here, we profile orphan G protein-coupled receptors in the dorsal root ganglia (DRG) following tumor infiltration, and observe a notable increase in GPR160 expression. Elevated Gpr160 mRNA and protein levels persist from postoperative day 6 for over 18 days in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
